Summarized by Masters of Longevity from Longevity Technology.
A new collaboration pairs glycan-based biological age testing with an exosome platform to expand inflammaging research and testing in Japan.
Key Takeaways
- Deal is really two deals folded into one.
- The pitch is that immune-aging biomarkers (GlycanAge’s specialty).
- In other words, the framework is signed, the study design isn’t finished yet.
